Article info
PDFA difficult case
Grey matter abnormality in progressive multifocal leucoencephalopathy
- Correspondence to Christopher Yuki Itoh, Department of Neurology, University of California Davis School of Medicine, Sacramento, CA 95817, USA; citoh{at}ucdavis.edu
Citation
Grey matter abnormality in progressive multifocal leucoencephalopathy
Publication history
- Accepted February 3, 2021
- First published March 30, 2021.
Online issue publication
January 09, 2022
Article Versions
- Previous version (9 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Progressive multifocal leukoencephalopathy during treatment with rituximab and CHOP chemotherapy in a patient with a diffuse large B-cell lymphoma
- Cerebellar progressive multifocal leucoencephalopathy identified by the shrimp sign
- Late relapse of progressive multifocal leucoencephalopathy postallogenic transplant in a young patient with CLL
- A hitherto unrecognised case of progressive multifocal leukoencephalopathy
- Progressive multifocal leukoencephalopathy following five lines of therapy and three autologous bone marrow transplants for multiple myeloma
- MRI pattern in asymptomatic natalizumab-associated PML
- Chronic intestinal pseudo-obstruction: how important is JC virus infection?
- Concomitant progressive multifocal leucoencephalopathy and primary central nervous system lymphoma expressing JC virus oncogenic protein, large T antigen
- Case definition for progressive multifocal leukoencephalopathy following treatment with monoclonal antibodies
- Pharmacovigilance during treatment of multiple sclerosis: early recognition of CNS complications